Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Clinical trial NCT06619236 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06619236
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-07
- Primary completion
- 2027-02-01
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.